SWEET Corporate Partners

SWEET corporate partners

SWEET e.V. acknowledges with gratitude the support from the following SWEET e.V. corporate members – in alphabetical order: Boehringer Ingelheim, DexCom Inc., Johnson & Johnson Diabetes, Lilly Diabetes Excellence Centre, Medtronic Europe, Sanofi.

SWEET Corporate Partners: Boehringer Ingelheim

Boehringer Ingelheim

Why do we participate in SWEET:
Boehringer Ingelheim’s core principles and vision (Value through Innovation) guide our commitment to diabetes. Our dedication is to serve humankind through research and the development of new medicines and therapies. The SWEET initiative offers the unique opportunity for Boehringer Ingelheim to learn from this pediatric network and to improve diabetes care for children and adolescents around the world.

WEBSITE OF BOEHRINGER INGELHEIM

SWEET Corporate Partners: DexCom

DexCom

Why do we participate in SWEET:
Dexcom is happy be corporate member of the SWEET study group because here we have a vehicle where we support Health Care Professionals to keep control of diabetes care and its out-comes.

WEBSITE OF DEXCOM

SWEET Corporate Partners: Johnson & Johnson

Johnson & Johnson

Why do we participate in SWEET:
Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886.

WEBSITE OF JOHNSON & JOHNSON

SWEET Corporate Partners: Lilly

Lilly

Why do we participate in SWEET:
Lilly is an innovation-driven pharmaceutical company with a long tradition in diabetes. We are developing a growing portfolio of innovative pharmaceutical products by applying research from our own worldwide laboratories, by collaborating with eminent scientific organizations, by making use of up-to-date technological tools, and by providing excellent service to our customers. Lilly Diabetes is committed to the success in the fight against diabetes by complementing therapeutic portfolio with non-pharmaceutical approaches. This commitment is exemplified by numerous programs focused on advancing the scientific and clinical understanding of diabetes and improving diabetes education and care. As a sign of Lilly´s commitment to diabetes, Diabetes Excellence Center (DEC) was established in Germany in 2007 to enhance diabetes prevention, awareness, education, research and patient care in Europe. DEC is also partnering with organizations such as SWEET to improve diabetes care in Europe.

WEBSITE OF LILLY

SWEET Corporate Partners: Medtronic

Medtronic

Why do we participate in SWEET:
Medtronic is proud to be part of SWEET since its inception and to support SWEET’s strong and growing network of Centers of Reference. SWEET’s objective to provide the best possible pediatric diabetes care based on high quality data, benchmarking and peer reviews, is fully aligned with Medtronic’s vision of transforming diabetes care together for greater freedom and better health. It is a pleasure to participate in such a positive and effective initiative successfully bringing together pediatric diabetes centers from a wide range of different countries to ensure improved outcomes for children with diabetes and their loved ones.

WEBSITE OF MEDTRONIC

SWEET Corporate Partners: Sanofi

Sanofi

Why do we participate in SWEET:
Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services and devices, including blood glucose monitoring systems. Sanofi markets both injectable and oral medications for people with type 1 or type 2 diabetes.

WEBSITE OF SANOFI

Back to Top